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INTRODUCTION 
India is frequently referred to as the diabetic capital of the world. 
Diabetes mellitus is widely prevalent in our country and its incidence is 
rising in alarming proportions. The worldwide prevalence of diabetes has 
risen dramatically over the past two decades, from an estimated 30 
million cases in 1985 to 177 million in 2000. Based on current trends, 
>360 million individuals worldwide will have diabetes by the year 2030. 
Although the prevalence of both type 1 and type 2 diabetes is increasing 
worldwide, the prevalence of type 2 diabetes is rising much more rapidly 
because of increasing obesity and reduced activity levels as countries 
become more industrialized. Worldwide estimates project that in 2030 the 
greatest number of individuals with diabetes will be 45–64 years of age   . 
According to the Diabetes Atlas published by the International 
Diabetes Federation (IDF), there are an estimated 40 million persons with 
diabetes in India in 2007 and this number is predicted to rise to almost 70 
million people in 2025 by which time every fifth diabetic subject in the 
world would be an Indian. Diabetes is a major cause of mortality, but 
several studies indicate that diabetes is likely underreported as a cause of 
death. A recent estimate suggested that diabetes was the fifth leading 
cause of death worldwide and was responsible for almost 3 million deaths 
annually (1.7–5.2% of deaths worldwide). 
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The real burden of the disease is however due to its micro and 
macro vascular complications which lead to increased morbidity and 
mortality. Atherosclerotic vascular diseases, particularly Coronary artery 
diseases (CAD), are leading causes of morbidity and mortality amongst 
diabetics. Interestingly apart from the known risk factors for CAD i.e., 
smoking, hypertension and obesity, current knowledge suggests the 
possible role of hypertriglyceridemia as an important risk factor for 
atherogenesis in diabetics. The ‘response- to- injury’ hypothesis of 
atherosclerosis states that the initial damage affects the arterial 
endothelium, leading to endothelial dysfunction. It has been hypothesized 
that hypertriglyceridemia induces endothelial dysfunction through the 
production of oxidative stress. This process may involve the over 
generation of superoxide anion, which in turn inactivates nitric oxide 
(NO). There is need for a simple investigation which can detect 
endothelial dysfunction at a much earlier date. Recently, much attention 
has been paid to the evidence that postprandial hypertriglyceridemia is an 
important contributing factor for the development of atherosclerosis in 
diabetes and trials are underway to determine if targeting triglycerides 
can halt the progress of atherosclerosis in diabetes. 
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REVIEW OF LITERATURE 
DIABETES MELLITUS 
Diabetes mellitus (DM) refers to a group of metabolic disorders 
which have a common denominator namely hyperglycemia. Factors 
contributing to hyperglycemia include reduced insulin secretion, 
decreased glucose utilization, and increased glucose production. The 
metabolic dysregulation associated with DM causes secondary 
pathophysiologic changes in multiple organ systems that impose a 
tremendous burden on the individual with diabetes and on the health care 
system.1  
Classification 
DM is classified on the basis of the pathogenic process that leads to 
hyperglycemia. The two broad categories of DM are designated type 1 
and type 2.  
 - Type 1 diabetes is the result of complete or near-total insulin deficiency.  
- Type 2 DM is a heterogeneous group of disorders characterized by 
variable degrees of insulin resistance, impaired insulin secretion, and 
increased glucose production. Type 2 DM is preceded by a period of 
abnormal glucose homeostasis classified as impaired fasting glucose (IFG) 
or impaired glucose tolerance (IGT). 
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ETIOLOGIC CLASSIFICATION OF DIABETES MELLITUS 
I. Type 1 diabetes (β-cell destruction, usually leading to absolute insulin 
deficiency) 
  A. Immune-mediated 
  B. Idiopathic 
II. Type 2 diabetes (may range from predominantly insulin resistance 
with relative insulin deficiency to a predominantly insulin secretory 
defect with insulin resistance) 
III. Other specific types of diabetes 
  A. Genetic defects of beta cell function characterized by mutations in 
1. Hepatocyte nuclear transcription factor (HNF) 4 (MODY 1) 
2. Glucokinase (MODY 2)  
3. HNF-1 (MODY 3) 
    4. Insulin promoter factor-1 (IPF-1; MODY 4) 
5. HNF-1 (MODY 5) 
6. NeuroD1 (MODY 6) 
          7. Mitochondrial DNA 
          8. Subunits of ATP-sensitive potassium channel 
          9. Proinsulin or insulin conversion 
  B. Genetic defects in insulin action 
          1. Type A insulin resistance 
          2. Leprechaunism 
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          3. Rabson-Mendenhall syndrome 
          4. Lipodystrophy syndromes 
  C. Diseases of the exocrine pancreas—pancreatitis, pancreatectomy, 
neoplasia, cystic fibrosis, hemochromatosis, fibrocalculous 
pancreatopathy, mutations in carboxyl ester lipase. 
  D. Endocrinopathies—acromegaly, Cushing's syndrome, glucagonoma, 
pheochromocytoma, hyperthyroidism, somatostatinoma, aldosteronoma 
  E. Drug- or chemical-induced—Vacor, pentamidine, nicotinic acid, 
glucocorticoids, thyroid hormone, diazoxide, beta-adrenergic agonists, 
thiazides, phenytoin, protease inhibitors, clozapine 
  F. Infections—congenital rubella, cytomegalovirus, coxsackie 
  G. Uncommon forms of immune-mediated diabetes—"stiff-person" 
syndrome, anti-insulin receptor antibodies 
  H. Other genetic syndromes sometimes associated with diabetes—
Down's syndrome, Klinefelter's syndrome, Turner's syndrome, Wolfram's 
syndrome, Friedreich's ataxia, Huntington's chorea, Laurence-Moon-
Biedl syndrome, myotonic dystrophy, porphyria, Prader-Willi syndrome 
IV. Gestational diabetes mellitus (GDM) 
Glucose intolerance may develop during pregnancy. Insulin 
resistance is related to the metabolic changes of late pregnancy and the 
increased insulin requirements may lead to IGT. GDM occurs in ~4% of 
pregnancies in the United States; most women revert to normal glucose 
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tolerance post-partum but have a substantial risk (30–60%) of developing 
DM later in life. 1 
Diagnosis of diabetes mellitus 
The National Diabetes Data Group and World Health Organization 
(WHO) have issued certain diagnostic criteria: 
• Symptoms of diabetes plus random blood glucose concentration 
11.1 mmol/L (200 mg/dL)a (or)  
• Fasting plasma glucose 7.0 mmol/L (126 mg/dL)b (or)  
• Two-hour plasma glucose 11.1 mmol/L (200 mg/dL) during an oral 
glucose tolerance testc 
aRandom is defined as without regard to time since the last meal. 
bFasting is defined as no caloric intake for at least 8 h. 
cThe test should be performed using a glucose load containing the 
equivalent of 75gms anhydrous glucose dissolved in water; not 
recommended for routine clinical use. 
Glucose tolerance is classified into three categories based on the FPG:  
 (1) FPG < 5.6mmol/L (100 mg/dL) is considered normal 
 (2) FPG = 5.6–6.9 mmol/L (100–125 mg/dL) is defined as IFG 
 (3) FPG ≥ 7.0 mmol/L (126 mg/dL) warrants the diagnosis of DM. 
Based on the OGTT, IGT is defined as plasma glucose levels between 7.8 
and 11.1 mmol/L (140 and 199 mg/dL) and diabetes is defined as a 
glucose > 11.1 mmol/L (200 mg/dL) 2 h after a 75-g oral glucose load. 
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Some individuals have both IFG and IGT. Individuals with IFG and/or 
IGT, recently designated ‘pre-diabetes’ by the American Diabetes 
Association (ADA), are at substantial risk for developing type 2 DM (25–
40% risk over the next 5 years) and have an increased risk of 
cardiovascular disease. 2 
Risk Factors for Type 2 Diabetes Mellitus 
1. Family history of diabetes (i.e., parent or sibling with type 2 diabetes)  
2. Obesity (BMI >25 kg/m2)  
3. Habitual physical inactivity 
4. Race/ethnicity (e.g., African American, Latino, Native American, 
Asian American, Pacific Islander)  
5. Previously identified IFG or IGT  
6. History of GDM or delivery of baby >4 kg (>9 lb)  
7. Hypertension (blood pressure >140/90 mmHg)  
8. HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride 
level >250 mg/dL (2.82 mmol/L)  
9. Polycystic ovary syndrome or acanthosis nigricans  
10. History of vascular disease1 
Pathophysiology 
Type 2 DM is characterized by impaired insulin secretion, insulin 
resistance, excessive hepatic glucose production, and abnormal fat 
metabolism. Obesity, particularly visceral or central (as evidenced by the 
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hip-waist ratio), is very common in type 2 DM. In the early stages of the 
disorder, glucose tolerance remains near-normal, despite insulin 
resistance, because the pancreatic beta cells compensate by increasing 
insulin output. As insulin resistance and compensatory hyperinsulinemia 
progress, the pancreatic islets in certain individuals are unable to sustain 
the hyperinsulinemic state. IGT, characterized by elevations in 
postprandial glucose, then develops. A further decline in insulin secretion 
and an increase in hepatic glucose production lead to overt diabetes with 
fasting hyperglycemia. Ultimately, beta cell failure may ensue.3 
Abnormal Muscle and Fat Metabolism in diabetes 
Insulin resistance, the decreased ability of insulin to act effectively 
on target tissues (especially muscle, liver, and fat), is a prominent feature 
of type 2 DM and results from a combination of genetic susceptibility and 
obesity. Insulin resistance is relative, however, since supernormal levels 
of circulating insulin will normalize the plasma glucose. Insulin 
resistance impairs glucose utilization by insulin-sensitive tissues and 
increases hepatic glucose output; both effects contribute to the 
hyperglycemia. Increased hepatic glucose output predominantly accounts 
for increased FPG levels, whereas decreased peripheral glucose usage 
results in postprandial hyperglycemia. In skeletal muscle, there is a 
greater impairment in non oxidative glucose usage (glycogen formation) 
than in oxidative glucose metabolism through glycolysis. Glucose 
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metabolism in insulin-independent tissues is not altered in type 2 DM. 
Hyperglycemia has been quoted to be the central process in the 
pathogenesis of the complications of diabetes. 
Increased Hepatic Glucose and Lipid Production 
In type 2 DM, insulin resistance in the liver reflects the failure of 
hyperinsulinemia to suppress gluconeogenesis, which results in fasting 
hyperglycemia and decreased glycogen storage by the liver in the 
postprandial state. Increased hepatic glucose production occurs early in 
the course of diabetes, though likely after the onset of insulin secretory 
abnormalities and insulin resistance in skeletal muscle. As a result of 
insulin resistance in adipose tissue and obesity, free fatty acid (FFA) flux 
from adipocytes is increased; leading to increased lipid synthesis, 
especially very low density lipoprotein (VLDL) and triglyceride (TGL) in 
hepatocytes. This lipid storage or steatosis in the liver may lead to non 
alcoholic fatty liver disease and abnormal liver function tests. This is also 
responsible for the dyslipidemia found in type 2 DM namely elevated 
TGL, reduced HDL, and increased small dense LDL (low density 
lipoprotein) particles. Both hyperglycemia and hyperlipidemia are 
important consequences of the disease that can trigger several 
inflammatory processes to produce larger damage at a later date.1 
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Diabetic Dyslipidemia 
Individuals with DM may have several forms of dyslipidemia. The 
most common pattern of dyslipidemia is hypertriglyceridemia and 
reduced HDL cholesterol levels. DM itself does not increase levels of 
LDL, but the small dense LDL particles found in type 2 DM are more 
atherogenic because they are more easily glycated and susceptible to 
oxidation. All forms of dyslipidemia are more common in type 2 DM 
than in type 1 DM.2 Recent studies indicate that hyperlipidemia could 
have an additive effect with hyperglycemia in diabetes and its 
complications. 
Post prandial metabolic dysregulation 
Two important processes involved in the development of 
atherosclerosis, the underlying cause of cardiovascular disease, are 
inflammation and coagulation activation. Although the exact mechanisms 
underlying atherogenesis are still not completely understood, vascular 
endothelial dysfunction is generally believed to be the starting point.  
 Under normal conditions, the multiple functional characteristics of 
the endothelium, including regulation of the vascular tone, 
thrombogenesis, vascular wall permeability, and cell growth, collectively 
protect the vascular system. Adequate production of nitric oxide has a 
pivotal role in the majority of these processes. Since endothelial functions 
cannot be measured directly, several indirect methods have been 
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developed to estimate these functions. However, only recently, the 
excessive and prolonged metabolic disturbances occurring in the 
postprandial state in type 2 diabetic subjects have regained interest as 
potential cardiovascular disease risk factors. The so-called traditional risk 
factors cannot fully explain the excessive cardiovascular disease risk of 
type 2 diabetic patients. Numerous studies indicate that postprandial 
metabolic derangements, most notably hyperglycemia and 
hypertriglyceridemia, which are exaggerated and prolonged in type 2 
diabetes, are important cardiovascular disease risk factors since they 
induce oxidative stress and endothelial dysfunctions.  
More than two thirds of patients with CAD have abnormal glucose 
metabolism. Most of them have impaired glucose tolerance in spite of a 
normal fasting glucose level. Postprandial glucose levels have been 
shown to have continuous, linear and direct relationship with 
cardiovascular and total mortality.4,5 Starting at only 80 mg/dl 
postprandial or post-challenge glycaemia, the cardiovascular risk begins 
to increase linearly and enhances by 58% as it reaches to 140 mg/dl - the 
point at which patients are traditionally classified as glucose intolerant or 
pre-diabetic.6 Coutinho et al showed a significant relationship between 
hyperglycemia and cardiovascular events.7 
Postprandial hyperglycemia leads to hyperlipemia, manifested as 
elevated levels of TGL, chylomicrons, and remnant lipoproteins. These 
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elevated and protracted post meal lipid levels are common manifestations 
of insulin resistance and the metabolic syndrome. Already over 200 years 
ago, William Heberden made the first observation regarding a 
postprandial effect on the circulation of blood.8 In the year 1979, 
Zilversmit postulated that atherosclerosis is a postprandial phenomenon. 
He proposed that postprandial accumulation of TRLs resulted from a 
reduction in the rate of clearance of TGL rich dietary remnant particles at 
the endothelial surface and promoted the development of endothelial 
dysfunction.9 Ever since, a large body of evidence has accumulated 
indicating a relation between postprandial dysmetabolism, especially 
hyperglycaemia and hypertriglyceridemia, and the risk of cardiovascular 
disease.  
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POSTPRANDIAL HYPERGLYCAEMIA 
Recent studies demonstrate that hyperglycemia induces an 
overproduction of superoxide by the mitochondrial electron-transport 
chain. Superoxide overproduction is accompanied by increased NO 
generation, due to endothelial NO synthase (eNOS) and inducible NO 
synthase (iNOS) uncoupled state, a phenomenon favouring the formation 
of the strong oxidant peroxynitrite, which in turn damages DNA. DNA 
damage is an obligatory stimulus for the activation of the nuclear enzyme 
poly (ADP-ribose) polymerase. Poly(ADP-ribose) polymerase activation 
in turn depletes the intracellular concentration of its substrate NAD+, 
slowing the rate of glycolysis, electron transport, and ATP formation and 
produces an ADP ribosylation of the GAPDH (glyceraldehyde-3-
phosphate dehydrogenase). These processes result in acute endothelial 
dysfunction in diabetic blood vessels that, convincingly, contributes to 
the development of CAD10. 
Several epidemiological studies have shown an association 
between two hour glucose concentrations after a 75 g glucose load (2h 
PPG) and the occurrence of cardiovascular disease in the general 
population. Thalhammer et al have shown that chronic hyperglycaemia 
has been associated with impaired endothelial function.11 
Ceriello and co-workers have shown that postprandial 
hyperglycaemia is accompanied by several alterations of the coagulation 
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system.12,13  Gresele et al showed that an oral glucose load in both healthy 
and type 2 diabetes patients caused a shortening of the half life of 
fibrinogen and an increase in plasma fibrinopeptide A and the fragments 
of prothrombin and factor VII.14 In addition, acute, short term 
hyperglycaemia resulted in a transient hyper-reactivity of platelets to high 
shear stress, combined with a significant rise of plasma vWF in patients 
with type 2 diabetes. Taken together, these findings suggest that 
hyperglycaemia may induce a hypercoagulable state. 
  In a study done by Esposito et al in 2002, healthy subjects and 
those with impaired glucose tolerance were administered consecutive 
pulses of intravenous glucose. They found increased circulating cytokine 
concentrations (interleukin-6 and tumour necrosis factor-α) to a greater 
extent than during similar blood glucose levels which were kept stable 
during a hyperglycaemic clamp. This effect was more pronounced in 
subjects with impaired glucose tolerance.15 The same study showed 
changes in interleukin-6 (but not tumour necrosis factor-α) plasma 
concentrations in type 2 diabetic patients after a carbohydrate meal.16 
Thus, blood glucose excursions may induce a proinflammatory response.  
 Shizukuda et al have demonstrated the cytotoxic effects of 
hyperglycemia in their study done in the year 2002.17 Several other in 
vitro studies demonstrated cytotoxic effects of high glucose levels in 
various cell types. Of interest is the demonstration by Risso and 
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colleagues that intermittent high glucose levels induced more apoptosis 
than constant corresponding glucose levels in human umbilical vein 
endothelial cells.18 
Four main molecular mechanisms underlying the hyperglycaemia- 
induced vascular damage have recently been reviewed, all of which are 
the result of intracellular hyperglycaemia.10 These include- 
1. Increased polyol pathway influx; 
2. Increased advanced glycation end-product formation; 
3. Activation of protein kinase C isoforms;  
4. Increased hexosamine pathway flux.  
     These seemingly different mechanisms are the result of a common 
single pathway, that is, overproduction of superoxide by the 
mitochondrial electron transport chain. This hyperglycaemia-induced 
oxidative stress ultimately results in modification of intracellular proteins 
resulting in an altered function, DNA damage, activation of the 
transcription factor nuclear factor-κB, causing abnormal changes in gene 
expression, decreased production of nitric oxide, and increased 
expression of cytokines, growth factors and procoagulant and 
proinflammatory molecules.10 Taken together, post load or postprandial 
glucose levels are associated with enhanced risk of cardiovascular disease.  
Most epidemiological studies addressing the contribution of post 
load glucose levels to cardiovascular disease risk, especially the early 
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ones, did not take into account the earlier mentioned classical risk factors, 
such as dyslipidaemia. These data indicate that post load glucose may not 
be an independent cardiovascular disease risk factor but rather a risk 
marker, suggestive of underlying other metabolic disturbances, such as 
insulin resistance and dyslipidaemia that may have an even greater impact 
on cardiovascular disease risk.  
POSTPRANDIAL HYPERTRIGLYCERAEMIA 
The role of elevated triglyceride (TGL) levels in the pathogenesis 
of atherosclerotic cardiovascular disease has remained a controversial 
issue. TGL, the major lipids in chylomicrons, and very-low-density 
lipoprotein (VLDL) particles, are closely related to the metabolism of 
other lipoproteins, including high-density lipoprotein (HDL) particles. 
 Increased serum TGL levels are associated with at least four 
pathogenic conditions: decreased serum HDL cholesterol levels, 
increased remnant lipoproteins, increased small dense low-density 
lipoprotein (LDL), and increased thrombogenesis, all of which are 
believed to expedite atherosclerosis. Even though considerable evidence 
supports the view that elevated TGL level is an independent risk factor 
for coronary artery disease (CAD), adjustment for covariates frequently 
weakens or eliminates the predictive significance of TGL. 
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TABLE 1: Hypertriglyceridemia (according to the NECP adult 
treatment panel III) 
 
In the insulin-resistant state the production of VLDL by the liver is 
inappropriately high. Together with a reduced lipoprotein lipase activity 
this results in high triglyceride concentrations, especially in the 
postprandial state. The large amount of TRLs (triglyceride-rich 
lipoproteins) and their prolonged residence time in the circulation may 
lead to increased exchange of the core lipid cholesteryl ester for 
triglycerides between TRL, LDL and HDL particles mediated by 
cholesteryl ester transfer protein. This process enriches LDL and HDL 
with triglyceride, and these particles are subsequently more readily 
hydrolysed by hepatic lipase resulting in smaller, denser LDL particles 
and lower concentrations of HDL.2  
These abnormalities may explain the characteristic diabetic 
dyslipidaemia, which is now recognised to be very atherogenic.19 Already 
in 1959, an association between plasma triglyceride concentrations and 
incident coronary heart disease was reported by Albrink et al.20 
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Vogel et al demonstrated impaired endothelial function in healthy 
subjects without risk factors for cardiovascular disease when subjected to 
a single high fat meal.21 This suggests that a fat challenge may induce 
several abnormalities independent of the underlying disorder.  
Murphy et al showed that doses of 20 g fat were capable of 
eliciting an insulin mediated release of lipoprotein lipase, an enzyme that 
catalyzes plasma TAG clearance. Thus there is impaired postprandial 
clearance of TAG in diabetic and prediabetic individuals either due to 
insulin resistance or decreased insulin secretion.22 
 A recently performed meta analysis including data of 57,000 
subjects from 17 studies demonstrated that fasting triglyceride 
concentrations were an independent risk factor for cardiovascular disease, 
also when adjusted for HDL cholesterol.23 An increase in plasma 
triglyceride by 1 mmol/l was associated with a relative risk of 1.3 for men 
and 1.8 for women.  
In general practice, serum lipid concentrations including 
triglycerides are measured in the morning after an overnight fast. 
However, the fasting value should be considered the nadir of the 24 hour 
TGL profile and could therefore be misleadingly low. In the past few 
years several clinical studies have suggested that high postprandial TRL 
may be related to coronary heart and/or carotid artery disease in non 
diabetic and diabetic subjects.24, 25, 26  
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 The Physician Health study, including 14,916 men aged 40–84 
years, with a follow up of seven years, showed that the non-fasting 
triglyceride concentrations strongly predicted incident myocardial 
infarctions, with a relative risk of 1.40 (95% confidence interval 1.10 to 
1.77) per 1.13 mmol/l increase. This study suggests that random or 
postprandial triglyceride concentrations are an important indicator of 
cardiovascular disease risk. 25  
Although fasting triglycerides are the most important determinant 
of postprandial triglycerides, it may be argued that in insulin resistant 
subjects with a delayed postprandial TRL clearance, non fasting TGL 
should be used to approximate overall TGL exposure. 27  
In male patients after a myocardial infarction, Karpe and co-
workers found that the progression of coronary lesions over five years 
was related to the postprandial plasma levels of small chylomicron 
remnants. 28,29 
 In line with these findings are coronary angiography data 
described by Mero et al, which suggest that especially small chylomicron 
remnants are implicated in the progression of CAD.30 
Postprandial coagulation activation by TRL was demonstrated by 
several investigators, however the underlying mechanism(s) are not fully 
understood.31,32 A study performed by Silveira et al suggests an important 
role for the intrinsic coagulation pathway, based on in vivo activation of 
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factor XI by triglyceride.31 Other prothrombotic changes occurring with 
an oral fat load are increased plasmin activator inhibitor-1 (PAI-1) 
activity and PAI-1 antigen.33 Postprandial lipaemia enhanced platelet P-
selectin expression without affecting other markers of platelet activation. 
Madhu et al studied the association between postprandial lipemia 
and endothelial dysfunction in type 2 DM and the association was found 
to be significant irrespective of the fasting triglyceride levels. This was 
independent of glycemic control and insulin sensitivity but was related to 
the interaction of diabetic state and obesity.34, 35  
 The effect of a high fat meal (50 g of fat) on cytokine 
concentrations, reflecting the inflammatory state, was studied by Nappo 
et al in healthy and type 2 diabetic patients. In healthy subjects, 
significant correlations were found between postprandial triglyceride and 
tumour necrosis factor-α levels, whereas in diabetic patients also a 
positive correlation between postprandial plasma triglyceride and 
interleukin-6 concentrations was observed. Antioxidant supplementation 
lowered the rise of the cytokines, suggesting that the cytokine response to 
triglycerides was mediated by oxidative stress.16  
Ryu et al showed that postprandial triglyceride levels are also 
directly related to angiographic progression of coronary and carotid 
atherosclerosis.36 MARS study showed that lowering levels of elevated 
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triglycerides by 20% to 40% reduces CAD rates by approximately 30% to 
40%.37  
This concept has also been proven in many diet related studies 
which suggest that targeting postprandial triglyceride may, in fact reduce 
the cardiovascular risk in these patients.38,39  The amount and type of 
carbohydrate consumed in a meal is a major determinant of the post-
prandial glucose surge. Diets with high glycemic index and low in fibre 
increase the risk of both cardiovascular disease and type 2 diabetes. 
Dietary fibre is effective at delaying gastric emptying, slowing digestion, 
and reducing post-prandial excursions of both glucose and fat. Minimally 
processed plant-based foods are natural sources of soluble and insoluble 
fibre that improve post-prandial dysmetabolism, reduce oxidant stress and 
inflammation, and lower the risks of CAD and diabetes. Consumption of 
nuts decreases meal-induced oxidative protein damage because they 
lower post-prandial oxidative stress and additionally provide 
antioxidants.40 Epidemiologic studies consistently indicate that 
consumption of nuts at least five times per week reduces CAD and 
diabetes risks by 30%. Protein of high biological quality such as egg 
whites, fish, skinless poultry breast meat, and whey protein (or other non 
fat dairy protein) when eaten with meals dampen down postprandial 
inflammation and can help prevent obesity. 
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To summarise, historically, in diabetic patients, most emphasis was 
laid on hyperglycaemia, whereas recent evidence demonstrates the 
importance of dyslipidemia, in particular hypertriglyceridemia, as a 
cardiovascular disease risk factor. Much importance has been given to 
increased LDL levels in diabetes, which is assumed to be the most 
important pathogenetic factor in the development of macro vascular 
events and aggressive LDL lowering strategies with statins form an 
integral part of treatment protocols in diabetes.  Although at present, 
epidemiological and long term intervention studies are largely lacking, in 
vivo data convincingly show an association between postprandial TRL 
and indicators of cardiovascular disease. Similar to postprandial 
hyperglycaemia, both in vivo and in vitro studies indicate that 
(postprandial) increases in triglycerides are proinflammatory, 
prothrombotic, and adversely affect several endothelial functions, by 
inducing oxidative stress. Therefore, it is feasible that prolonged 
postprandial hypertriglyceridemia leads to an atherogenic environment in 
vivo. However, as for postprandial hyperglycemia the evidence for 
postprandial hypertriglyceridemia as independent in cardiovascular 
disease is still scanty.  
Although the beneficial effect of therapy targeting postprandial 
dysmetabolism still needs to be established, studies assessing the true 
atherogenic exposure of the vascular system in high risk patients should 
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perhaps abandon the classical glucose centred view and use physiological 
tests combining glucose and lipid loads. Most studies mentioned earlier 
demonstrated the effects of postprandial dysmetabolism on a single and 
rather artificial challenge, like a liquid 75 g glucose or liquid fat load. In 
daily life, most meals consumed are mixed and of solid consistence.  
Ceriello and co-workers showed a cumulative adverse effect of 
postprandial hypertriglyceridemia and hyperglycaemia on endothelial 
function.41 The effect of a single component challenge possibly 
underestimates the real life postprandial dysmetabolic state and therefore 
the use of standardised mixed meal containing of at least 75 g of 
carbohydrates and 50 g of fat in future postprandial (intervention) studies 
is recommended.42 
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AIMS AND OBJECTIVES 
The aims of the study were- 
1. To assess the value of postprandial hypertriglyceridemia as a 
marker of macro vascular events in type 2 diabetes mellitus. 
2. To compare postprandial with fasting triglyceride levels and 
standard lipid ratios in predicting macro vascular complications.  
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MATERIALS AND METHODS 
THE STUDY GROUP 
The study was conducted on patients attending the out patient 
department of Government Rajaji Hospital, Madurai. Approval from the 
hospital ethical committee was obtained.  
STUDY DESIGN 
The study was a case control study conducted for a period of one 
year between July 2007- June 2008  
Inclusion criteria 
• Patients with new onset diabetes mellitus were included in the 
study.  
• Twenty two healthy controls without diabetes or its complications 
were also included in the study for comparison. 
Exclusion criteria 
• Patients on lipid lowering agents. 
Diagnosis of Type 2 diabetes mellitus was made by clinical details 
and routine blood investigations including fasting and postprandial blood 
sugar values. The WHO criteria were employed for the diagnosis of 
diabetes mellitus.2  
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The presence of absence of macro vascular complications was made 
on the basis of the following: 
1. Clinical features suggestive of macro vascular events like CAD, 
stroke, hypertension and peripheral vascular disease.   
2. Electrocardiogram 
3. Echocardiogram. 
 METHODS 
 After the diagnosis of Type 2 diabetes mellitus and its complications, 
patients were divided into 3 groups based on the presence or absence of 
complications as follows- 
Group I:    Controls 
Group II:   Type 2 DM cases without Macro vascular Complications 
Group III: Type 2 DM cases with Macro vascular Complications 
The study groups were also divided into three categories based on 
the body mass index as follows1- 
Obesity: BMI >30kg/m2 
Overweight: BMI >25.0-29.9kg/m2 
Normal weight: BMI 18.5-24.9kg/m2 
Underweight: BMI <18.5kg/m2 
BMI=Weight (in Kg)/ Height (in meter2) 
All the selected patients were subjected to a high fat meal which 
consisted of whipped cream (containing 75 grams of fat, five grams of 
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carbohydrate and 6 grams of protein per square meter of body surface 
area). For lipid analysis, blood samples were collected after 8 hours of 
fasting, two hours and four hours of postprandial state after giving high 
fat meal. Serum was separated and stored in the refrigerator. From the 
serum, total Cholesterol, HDL and Triglycerides were estimated 
separately by using ENZYMATIC COLORIMETRIC METHOD. 
From the above values, LDL-C was estimated by using 
FRIEDEWALD formula 
LDL-C= Total Cholesterol - (HDL+TGL/5) 
The enzymatic method was used to estimate serum cholesterol 
values. Due to the specificity of enzymes, the enzymatic method is the 
most accurate and reference method for the estimation of Cholesterol. 
Dyslipidemia was defined by one or more of the following- 
1. Total Cholesterol (TC)      >200mg/dl 
2. HDL Cholesterol              <35mg/dl  
3. LDL Cholesterol               >100mg/dl 
4. Triglycerides                     >150mg/dl 
 The standard lipid ratios (TC/HDL, LDL/HDL) were also 
calculated. 
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2002).
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 Using this software, range, frequencies, percentages, means, 
standard deviations, chi square and ‘p’ values were calculated. Kruskul 
Wallis chi-square test was used to test the significance of difference 
between quantitative variables. A 'p' value less than 0.05 is taken to 
denote significant relationship. 
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RESULTS AND STATISTICAL ANALYSIS 
EPIDEMIOLOGY 
Majority of the patients were from in and around Madurai city. The 
total number of patients included in the study was 68. Twenty two 
controls were also included in the study for comparative analysis.  
Among the total of 68 Type 2 diabetes mellitus patients, 44 
diabetic patients [Female (F)-18; Male (M)-26] had no evidence of 
macro vascular complications (Group-II), whereas 24 diabetic patients 
(F-14; M-10) had evidence of macro vascular complications (Group-III). 
Out of the 22 controls (group I), 10 were female and 12 were male. 
They had no evidence of diabetes or its complications after clinical and 
laboratory evaluation. 
The age of the controls ranged from 36 to 60 years with a mean age 
of 51.2+7.9 years. The age of the patients in group II ranged from 32-62 
years with a mean of 50.4+9.4 years, while that of group III ranged from 
45-67 years with a mean of 56.4+6.6 years. Twenty two patients in group 
II (50%) and 11 patients in group III (45.8%) were in the age group of 51-
60 years. The age distribution of the patients is shown in table 2. 
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TABLE 2: AGE DISTRIBUTION 
Group I Group II Group III Age group 
No. % No. % No. % 
Up to 40 yrs 3 13.6 7 15.9 - - 
41-50 7 31.8 12 27.3 7 29.2 
51-60 12 54.3 22 50 11 45.8 
Above 60 yrs - - 3 6.8 6 25 
Total 22 100 44 100 24 100 
Range 
Mean 
S.D. 
36-60 
51.2 
7.9 
32-62 
50.4 
9.4 
45-67 
56.4 
6.6 
 
The age groups of the cases and controls were comparable and 
there was no statistical difference (p=0.0788). 
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TABLE 3: SEX DISTRIBUTION 
Group I Group II Group III  
No. % No. % No. % 
Males 12 54.5 26 59.1 10 41.7 
Females 10 45.5 18 40.9 14 58.3 
Total 22 100 44 100 24 100 
 
It was observed that the female: male ratio was almost equal in 
groups I (1:1.2), a slightly higher ratio in group III (1.4:1) and lower 
in group II (1:1.4).  
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       Patients and controls were classified as overweight, normal weight 
and underweight according to the body mass index. Out of 22 controls, 14 
(63.6%) were in the normal weight patients as compared to 3 (13.6%) in 
the overweight patients. In group II, 31 out of 44 (70.5%) were in the 
normal weight patients as compared to 10 (22.7%) in the overweight  
patients. In group III, 15 out of 24 (62.5%) were normal weight patients 
compared to 6(25%) overweight patients. The results are shown in table 4. 
TABLE 4: BODY MASS INDEX 
Group I Group II Group III  
BMI No. % No. % No. % 
Underweight (<20) 5 22.7 3 6.8 3 12.5 
Normal weight (20-25) 14 63.6 31 70.5 15 62.5 
Overweight (>25) 3 13.6 10 22.7 6 25 
Range 
Mean 
S.D. 
16.9-29 
22.6 
3.1 
19.4 
24 
3 
18.8-30.4 
23.7 
3.1 
‘p’ 0.6126 
Not Significant 
 
The BMI of the three groups was comparable and there was no 
statistical difference (p=0.6126). 
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BIOCHEMICAL ANALYSIS 
Analysis of lipid profile was done in relation to the three study 
groups. The results are summarised in table 5. 
TABLE 5: LIPID PROFILE 
Group I Group II Group III  
Parameter No. % No. % No. % 
Total Cholesterol 
Normal ( < 200) 
High ( > 200) 
 
18 
4 
 
81.8 
18.2 
 
19 
25 
 
43.2 
56.8 
 
10 
4 
 
41.7 
58.3 
Range 
Mean 
S.D. 
150-265 
188.6 
27.7 
150-280 
208.2 
31.8 
160-270 
212.5 
31 
‘p’ 0.0202 Significant 
 
The prevalence of hypercholesterolemia was more in group II 
and III than controls (57.5% in diabetics compared to 18.2% in 
controls) and the difference was statistically significant (p=0.0202). 
There was no significant difference in HDL or LDL values between 
the three groups. 
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     Fasting (0 hr) and postprandial blood sugar values (2 and 4 hours) 
were analyzed in the three groups. The mean FPG in group I was 
81.1+12.7 mg/dl compared to 128.5+32.6 mg/dl in group III. On the other 
hand mean 2 hour PPG values in group I were 125.3+8.5 mg/dl as 
opposed to 202.6+45.1 mg/dl in group III. The results are summarised in 
table 6.  
TABLE 6: BLOOD SUGAR VALUES AT 0, 2, 4 hrs 
Group I Group II Group III  Blood 
Sugar at No. % No. % No %. 
0 hour 
Normal 
High 
 
22 
- 
 
100 
- 
 
16 
28 
 
36.4 
63.6 
 
5 
19 
 
20.8 
79.2 
2 hours 
Normal 
High 
 
22 
- 
 
100 
- 
 
7 
37 
 
15.9 
84.1 
 
1 
23 
 
4.2 
95.8 
4 hours 
Normal 
High 
 
22 
- 
 
100 
- 
 
6 
38 
 
13.6 
86.4 
 
2 
22 
 
8.3 
91.9 
 
 Mean S.D. Mean S.D Mean S.D. ‘p’ 
0 hour 81.1 12.7 115.5 29.4 128.5 32.6 0.0001 
Significant
2 hours 125.3 8.5 173.8 30.7 202.6 45.1 0.0001 
Significant
4 hours 86.1 17.4 148.9 43 170.6 39.3 0.0001 
Significant
 
All the three values were more in the groups II and III. The 
difference between the three groups was statistically significant 
(p=0.0001). 
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   Fasting TGL levels (0 hr) and post load TGL levels (2 and 4 hours) 
were analysed. The mean fasting TGL values were 121+19.8mg/dl in 
group I, 156+63.1mg/dl in group II, 184+68.7mg/dl in group III. The 
mean 4-hrs post load TGL values were 131.5+29.4mg/dl in group I, 
217+96.1mg/dl in group II, 264+101.7mg/dl in group III. TGL values 
remained persistently elevated in 65.9% (n=29) of patients in group II 
and 83.3% (n=20) of patients in group III compared to only 18.2% (n=4) 
of patients in group I. 
TABLE 7: TGL levels at 0, 2 and 4 hours 
Group I Group II Group III   
TGL at No. % No. % No %. 
0 hour 
Normal 
High 
 
22 
- 
 
100 
- 
 
30 
14 
 
68.2 
31.8 
 
12 
12 
 
50 
50 
2 hours 
Normal 
high 
 
18 
4 
 
81.8 
18.2
 
15 
29 
 
34.1 
65.9 
 
4 
20 
 
16.7 
83.3 
4 hours 
Normal 
high 
 
18 
4 
 
81.8 
18.2
 
15 
29 
 
34.1 
65.9 
 
4 
20 
 
16.7 
83.3 
 
 Mean S.D. Mean S.D. Mean S.D. ‘p’ 
0 hour 121 19.8 156.4 63.1 184.8 68.7 0.0027 
Significant 
2 hours 140.4 19.8 209.7 86.3 258.2 87.4 0.0001 
Significant 
4 hours 131.5 29.4 217 96.1 264.5 101.7 0.0001 
Significant 
The difference was statistically significant, indicating that 
postprandial hypertriglyceridemia (p=0.0027), may be more 
important in macro vascular complications than fasting TGL 
(p=0.0001).   
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Table 8 shows the baseline characteristics of the three groups. Age, 
BMI, LDL, and HDL cholesterol values were comparable. 
 
TABLE 8: BASELINE CHARACTERISTICS OF PATIENTS 
 
 GROUP I    
(n=22) 
GROUP II 
(n=44) 
GROUP III 
(n=24) 
‘P’ 
value 
Age(yrs)  51.2+7.9 50.4+9.4 56.4+6.6 0.0788(NS)
Male/Female(%) 54.5/45.5 59.1/40.9 41.7/58.3 - 
BMI(kg/m2) 22.6+3.1 24+3 23.7+3. 0.6126(NS)
FPG (mg/dl)  81.1+12.7 115.5+29.4 128.5+32.6 0.0001(S) 
FTGL(mg/dl)  121+19.8 156.4+63.1 184.8+68.7  0.0027(S) 
LDL(mg/dl) 112.3+30.3 122.6+33.6 126.8+27.7 0.1311(NS)
HDL(mg/dl) 44.8+8.1 47+10.7 45.2+10.8 0.5372(NS)
TC(mg/dl) 188.6+27.7 208.2+31.8 212.5+31 0.0202(S) 
Values are mean+S.D unless specified. FTGL=fasting triglyceride 
NS=not significant; S=significant 
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Hypertriglyceridemia at four hours after fat meal was compared 
between the three groups. There was significant difference in values 
between groups I and III (p=0.0001), groups I and II (p=0.0006), 
groups I, II and III (p=0.0001). Table 9 shows the comparative analysis 
of hypertriglyceridemia in relation to various groups. 
TABLE 9: HYPERTRIGLYCERIDEMIA IN VARIOUS GROUPS 
Group I(22) Group II(44) Group III(24) 
Hypertriglyceridemia No. % No. % No. % 
Present (TGL >150) 4 18.2 29 65.9 20 83.3 
Absent (TGL <150) 18 81.8 15 34.1 4 16.7 
TGL at 4 hours 
Range 
Mean 
S.D. 
 
62-192 
131.5 
29.4 
 
88-392 
217 
96.1 
 
80-398 
264 
101.7 
‘p’ value for 
    1. Group I & II 
    2. Group I & III 
    3. Group II & III 
    4. Groups I,II&III 
 
0.0006  Significant 
0.0001 Significant 
0.2122 Not Significant 
0.0001 Significant 
 
These results indicate that persistent hypertriglyceridemia at 
four hours post load was seen more in patients with macro vascular 
complications. 
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Mean cholesterol values were higher in the patients with 
hypertriglyceridemia (215+33.2mg/dl) than in patients without 
hypertriglyceridemia (189.1+21.7mg/dl).  
TABLE 10: HYPERTRIGLYCERIDEMIA AND TOTAL 
CHOLESTEROL 
Total Cholesterol 
Normal  Abnormal 
 
No % No % 
Mean S.D. 
 
‘p’ 
 
Present  
(TGL>150)(53) 
18 34 35 66 215.4 33.2 
Absent  
(TGL<150)(37) 
29 78.4 8 21.6 189.1 21.7 
 
0.0002 
Significant
 
High cholesterol values correlated significantly with high TGL 
values (p=0.0002).  
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Correlation between 4-hr post load hypertriglyceridemia and blood 
sugar was analyzed. Patients with hypertriglyceridemia had higher mean 
glucose values (2-hr PPG 188.2+40.7mg/dl, 4-hr PPG 160+42.6mg/dl) 
than those who did not have hypertriglyceridemia (2-hr PPG 
143+28mg/dl, 4-hr PPG 109+40.5mg.dl). The results are summarized in 
table 11.  
TABLE 11: HYPERTRIGLYCERIDEMIA AND BLOOD SUGAR
  
It was found that hypertriglyceridemia correlated significantly 
with both fasting and postprandial blood sugar values. The 4-hr PPG 
correlated better with hypertriglyceridemia (p=0.0001) than fasting 
blood sugar (p=0.0004). From these results, it is seen that 4-hr post 
prandial hyperglycemia and hypertriglyceridemia correlated 
significantly in the presence of macro vascular complications. 
 
Fasting B.S. 2 hours B.S. 4 hours B.S.  
Hypertriglyceridemia Mean S.D. Mean S.D. Mean S.D. 
Present (TGL >150) 120.5 34.1 188.2 40.7 160.4 42.6 
Absent (TGL <150) 96.4 23.5 143 28 109.1 40.5 
‘p’  0.0004 
Significant 
0.0001 
Significant 
0.0001 
Significant 
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The 4-hr post load hypertriglyceridemia was analyzed in relation to 
gender. Although the prevalence of hypertriglyceridemia was almost 
equal among males (49.1%) and females (50.9%), the mean TGL values 
were higher in females (234.9+107.1) than in males (185.9+84.8). The 
results are summarized in table 12.  
TABLE 12: HYPERTRIGLYCERIDEMIA AND GENDER 
Gender  
Male Female 
 
Hypertriglyceridemia 
No. % No. % 
Present (TGL >150)(53) 26 49.1 27 50.9 
Absent (TGL <150)(37) 22 59.5 15 40.5 
Mean (TGL at 4 hrs) 
S.D.  
185.9 
84.8 
234.9 
107.1 
‘p’ 0.0281 
Significant 
 
The difference was found to be statistically significant 
(p=0.0281).  
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Correlation between post load hypertriglyceridemia and body mass 
index was analyzed. TGL values were high in 15 patients (28.3%) in the 
overweight group compared to three patients (5.7%) in the underweight 
group.  
 
TABLE 13:  HYPERTRIGLYCERIDEMIA AND BMI 
BMI 
Under 
weight 
Normal 
weight 
Over 
weight 
 
Hyper 
triglyceridemia 
No. % No. % No. % 
Mean S.D. 
 
‘p’ 
Present  
(TGL >150)(53) 
3 5.7 35 66 15 28.3 24.4 3.1 
Absent  
(TGL <150)(37) 
8 21.6 25 67.6 4 10.8 22.4 2.8 
 
0.0124 
Significant 
 
The correlation was statistically significant (p=0.0124).  
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The 4-hr hypertriglyceridemia was compared with standard lipid 
ratios. Although there was no significant correlation between triglyceride 
levels and standard lipid ratios, a slightly higher TC/HDL and LDL/HDL 
ratios were seen in patients with hypertriglyceridemia than those without 
it. The results are shown in tables 14 and 15. 
TABLE 14: HYPERTRIGLYCERIDEMIA AND TC/HDL 
RATIO 
TC/ HDL ratio  
Hyper 
triglyceridemia Normal  Abnormal Mean 
 
S.D. 
 
‘p’ 
 
 
Present  
(TGL >150)(53) 
 
33 
 
62.3 
 
20 
 
37.7 
 
4.9 
 
1.35 
 
Absent  
(TGL <150)(37) 
 
23 
 
62.2 
 
14 
 
37.8 
 
4.25 
 
0.75 
 
 
0.8328 
Not 
significant 
  
It was observed that the mean TC/HDL ratios were 4.9+1.35 in 
the patients with hypertriglyceridemia compared to 4.25+0.75 in 
patients without it. 
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TABLE 15: HYPERTRIGLYCERIDEMIA AND LDL/HDL 
RATIO 
LDL/ HDL ratio  
Hyper 
triglyceridemia Normal  Abnormal Mean S.D. 
 
‘p’ 
 
 
Present  
(TGL >150)(53) 
 
41 
 
77.4 
 
12 
 
22.6 
 
2.91 
 
0.93 
 
Absent  
(TGL <150)(37) 
 
32 
 
86.5 
 
5 
 
13.5 
 
2.53 
 
0.73 
 
 
0.4151 
Not 
significant 
 
The mean LDL/HDL ratio was 2.91+0.93 in patients with 
hypertriglyceridemia in comparison with patients without 
hypertriglyceridemia where the ratio was 2.53+0.73. The correlation 
was not significant statistically.  
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DISCUSSION 
Meal absorption is a complex phenomenon and postprandial 
hyperlipidemia and hyperglycemia are simultaneously present the post 
absorptive phase, particularly in patients with type 2 diabetes mellitus and 
IGT. In non diabetic subjects, there is evidence that postprandial 
hypertriglyceridemia is a risk factor for CVD, whereas in diabetic 
subjects, postprandial hyperglycemia has been recently proposed as an 
independent risk factor for CVD with hyperlipidemia as an emerging risk 
factor. The distinct role and relative importance of these two factors in the 
pathogenesis of CVD in diabetes is a matter of debate. 
This study was done to highlight postprandial hypertriglyceridemia 
as a significant risk factor for vascular events. Fasting triglycerides, 
representing triglyceride metabolism under relaxation, have not generally 
been accepted as an independent risk factor for atherosclerosis including 
coronary artery disease. Individuals with normal fasting triglyceride 
levels exhibit highly varying postprandial triglyceride concentrations in 
the postprandial hours of a fatty test meal. Therefore, postprandial lipemia, 
representing triglyceride metabolic capacity under challenge, is 
considered to be more informative for assessing the role of triglyceride 
metabolism in the development of atherosclerosis. Consequently, a 
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number of case–control studies showed impaired triglyceride metabolic 
capacity, defined as increased and prolonged postprandial 
hypertriglyceridemia, to be closely linked to the presence of CAD.  
Many of the observations made in our study correlated well with 
previous studies.  
Most diabetic patients in this study were in the normal weight 
group (70.5% in uncomplicated diabetes and 60.5% in complicated 
diabetes). According to Indian data, almost 80% of type 2 DM patients in 
India are normal weight as compared to 60-80% of diabetics from west. 
The findings from our study correlated well with previous data from India 
as shown in the following table.  
TABLE 16: PROFILE OF DIABETIC PATIENTS FROM 
INDIA (past observations) 
Centre Obese Non obese Lean 
Cuttack43 7.8 65.8 26.4 
Hyderabad44 25.4 56.7 17.9 
Madras45 32.9 63.5 3.5 
Our study 23.8 66.5 9.7 
Values in percentage 
 
The mean fasting triglyceride levels in our study were 
121+19.8mg/dl in the control group, 156.4+63.1mg/dl in uncomplicated 
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diabetes and 184.8+68.7mg/dl in complicated diabetes.  This is in 
concordance with various Indian studies done in the past to ascertain 
triglyceride levels in normal individuals as shown in table 16. 
TABLE 17: MEAN TRIGLYCERIDE LEVELS IN NORMAL 
INDIAN URBAN POPULATION 
First 
Author 
Year Age-
Group 
Place Sample 
Size 
Triglycerides 
mg/dl 
Gandhi BM 1982 20-70 Delhi 200 124.0±29 
Vasisth S 1990 30-70 Delhi 186 128.1±30 
Reddy KS 1992 25-64 Delhi 1581 110.2±45 
Gopinath N 1994 25-64 Delhi 1345 131.0±54 
Gupta R 1997 20-80 Jaipur 199 126.1±55 
Gupta R 2002 20-80 Jaipur 1123 144.6±70 
 
In the present study, the incidence of baseline 
hypercholesterolemia (p=0.0202) and hypertriglyceridemia (p=0.0027) 
was more in the diabetic patients than in controls and more so in 
complicated diabetes. This has been well emphasized in literature. 
Diabetic patients invariably have dyslipidemia sometime in the course of 
the disease.2 This was also observed in studies done by Syvanne et al.46, 
West et al47 and Fontbonne et al48 in patients with diabetes and impaired 
glucose tolerance. There was good correlation noted between insulin 
resistance and plasma TGL concentration, as TGL may influence an early 
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step in the insulin action pathway; alternatively, insulin resistance may 
cause hypertriglyceridemia.49  
 A study conducted by Rajmohan et al in South Indian type 2 
diabetic subjects revealed that the prevalence of CAD was significantly 
higher among patients with isolated hypercholesterolemia, isolated high 
LDL, and isolated low high-density lipoprotein levels compared to 
normolipidemic individuals, but not in those with isolated 
hypertriglyceridemia.50 In contrast, Anderson et al showed that CAD was 
higher in patients with isolated hypertriglyceridemia.51 In our study, 
fasting cholesterol levels correlated significantly with triglyceride levels 
(p=0.0002) and both were high in patients with vascular events. Another 
observation made in this study was that there was no significant 
difference in the LDL or HDL cholesterol values between the three 
groups and triglycerides were elevated even with other lipoprotein 
measures in the normal range. This can be explained by the fact in that 
diabetic patients, altered morphology of the lipoprotein structure may 
contribute more to atherogenesis rather than the absolute value (small 
dense atherogenic LDL).1,2 
All the patients who had fasting triglyceridemia also had elevated 
postprandial TGL. This is in accordance with various studies in the past 
which have made the observations that elevated postprandial TGL levels 
have been seen in persons with fasting hypertriglyceridemia.46  There was 
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also good correlation between fasting (p=0.0006) and postprandial blood 
sugar (p=0.0001) and postprandial triglyceridemia in patients with 
vascular events. This has been noted in the previous study done by 
Ceriello et al where they proved the independent and cumulative role of 
postprandial hypertriglyceridemia and hyperglycemia in the causation of 
endothelial dysfunction in diabetes.41 
It was seen in our study that persistent triglyceridemia at four hours 
post fat meal was seen in 83.3% of diabetic patients with macro vascular 
complications and 65.9% of patients without complications, whereas it 
was seen only in 18.2% of controls (p=0.0001). It is in concordance with 
various studies in the past which have also proved a consistent 
relationship between macro vascular complications in diabetes and 
postprandial lipids.  Patsch et al.53 showed that increased postprandial 
TGL levels were independently predictive of severe CAD. The 
Atherosclerosis Risk in Communities (ARIC) trial showed similar 
observations. 54 Another study done by Patsch et al also demonstrated that 
postprandial TGL is important for the propensity for atherosclerosis.55 
Golay et al have found in their study that postprandial lipids are 
frequently being neglected as important determinants of coronary events 
in patients with type 2 diabetes mellitus.56 
It was found in our study that postprandial (post load) 
triglyceridemia (p=0.0027) correlated better that fasting triglyceridemia 
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with vascular events (p=0.0001). Gambhir et al (1999) from Noida, India 
have shown that there is significant elevation of triglycerides in diabetics 
in the postprandial state which are further associated with increased 
oxidative stress. 
It has been shown in past studies that there is some evidence for 
TGL as an independent risk factor in certain subgroups, for example, 
women 50–69 years of age47 and men with low total cholesterol levels.57 
A meta-analysis of 17 population-based prospective studies, which 
included 46000 men and 11000 women, revealed a 30%; and 75%; 
increased risk of CAD, respectively, for TGL levels.58 In our study also, 
women had significantly higher levels of postprandial triglycerides as 
compared to men, especially in complicated diabetes (p=0.0281). 
Some studies have indicated that there is an increased risk of CAD 
in the presence of TGL levels >204 mg/dl when the ratio of LDL-
cholesterol to HDL-cholesterol exceeds five.59, 60 Though standard lipid 
ratios did not correlate well with postprandial triglyceride levels in our 
study, the mean lipid ratios (TC/HDL, LDL/HDL) were found to be 
higher in patients with hypertriglyceridemia (4.9, 2.91) than those without 
it (4.25, 2.53).  
The above observations demonstrate a good relationship between 
postprandial lipemia and atherosclerosis, and suggest that postprandial 
TGL levels may be a better indicator of atherogenicity than fasting levels. 
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Therefore, postprandial triglyceride measurements, especially in high risk 
groups may give important information for risk assessment and planning 
of treatment strategies for prevention of vascular complications. 
 However, the protocol for measuring postprandial 
hypertriglyceridemia has to be formulated, and it is necessary to 
formulate precise guidelines on the time intervals for measuring 
postprandial TGL, and the fat load to be used. The normal cut-off values 
for TGL also have to be internationally standardized. If these guidelines 
are established, simple measurement of post load triglyceride and 
subsequent dietary or pharmacological intervention may help to detect or 
prevent endothelial dysfunction in diabetes, thus alleviating the mortality 
and morbidity associated with the disease.   
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Summary  
The study “postprandial hypertriglyceridemia as a risk factor for 
macro vascular complications in type 2 diabetes mellitus” was a case 
control study conducted on patients visiting the out patient department of 
Government Rajaji Hospital, Madurai. Sixty eight patients with type 2 
diabetes mellitus and 22 healthy controls were included in the study. 
Selected patients and controls underwent clinical and biochemical 
evaluation including blood sugar, lipid profile and cardiac function to 
detect the presence of macro vascular complications of diabetes. Selected 
patients and subjects were subjected to a high fat meal and plasma 
triglycerides were measured two and four hours after fat challenge. It was 
observed that post load hypertriglyceridemia correlated better than fasting 
triglycerides in patients with macro vascular complications. It was also 
observed that persistent postprandial hypertriglyceridemia was observed 
in diabetic patients with complications.  
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Conclusions  
1.  Dyslipidemia was seen in significant proportion of diabetic patients, 
especially those with complications.  
2.  Persistent and significant post load hypertriglyceridemia was observed 
in new diabetic patients with macro vascular complications compared to 
controls; hence it is a useful marker for predicting vascular complications 
in type 2 diabetes mellitus.  
3.  Postprandial hypertriglyceridemia was more significant than fasting 
triglyceridemia in complicated diabetes.  
4.  Hypertriglyceridemia was observed independent of LDL, HDL and 
standard lipid ratios in patients with vascular disease. Hence it may 
represent an independent risk factor for vascular events in diabetes.  
5.   Although the emphasis in recent times is mainly on LDL cholesterol 
in type 2 diabetes and metabolic syndrome, postprandial TGL increase 
may be equally or more important than LDL cholesterol in causation of 
vascular events. 
6.  Detecting and correcting early postprandial hypertriglyceridemia with 
the help of a standardized fat challenge test may be a useful therapeutic 
option in halting endothelial dysfunction and hence macro vascular 
complications in diabetes.  
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                                                        PROFORMA 
Name:                                             Age:                    Sex: 
 
Occupation:                                    Address:                                                                                 
Height:                                                          
Weight: 
BMI: 
 
Diabetes  :                                        Yes / No    
Type        :                                        Type 1/Type 2 DM 
Duration  :   
Treatment: 
 
Hypertension :                                  Yes /No 
Coronary Artery Disease :                Yes /No 
Cerebro Vascular Disease :               Yes /No 
Peripheral Vascular Disease :           Yes /No 
 
Diet History:                                    Vegetarian/Non Vegetarian 
Personal History:                              Smoker/Alcoholic 
Family History: 
 
General examination: 
 
Pulse:               BP:             Temp:              RR: 
CVS: 
RS: 
ABDOMEN: 
CNS: 
 
INVESTIGATION: 
 
HB:         TC:                DC:                         Urine Alb:      Sug:        Dep: 
SUGAR: 
Fasting                2hrs PP                    4hrs PP 
UREA:                    CREATININE: 
 
LIPID PROFILE- TC               LDL                  HDL                    VLDL 
 
TRIGLYCERIDES: 
Fasting              2hrs PP                    4hrs PP 
 
ECG: 
     
ECHO: 
  
FIGURE 1: PATHOPHYSIOLOGY OF TYPE 2 DIABETES 
MELLITUS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2: OXIDATIVE STRESS AND ENDOTHELIAL 
DAMAGE 
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FIGURE 3: AGE DISTRIBUTION OF PATIENTS 
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FIGURE 4: MEAN BLOOD SUGAR VALUES 
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FIGURE 5: MEAN TRIGLYCERIDE LEVELS 
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FIGURE 6: 4-HOUR HYPERTRIGLYCERIDEMIA IN VARIOUS 
GROUPS 
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FIGURE 7: CORRELATION BETWEEN 
HYPERTRIGLYCERIDEMIA AND BLOOD SUGAR VALUES 
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FIGURE 8: HYPERTRIGLYCERIDEMIA VERSUS GENDER 
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FIGURE 9: HYPERTRIGLYCERIDEMIA VERSUS BMI 
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